RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma

For the majority of patients with pancreas cancer, the high metastatic proclivity is life-limiting. Some patients, however, present with and succumb to locally destructive disease. A molecular understanding of these distinct disease manifestations can critically inform patient management. Using gene...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell
Asıl Yazarlar: Whittle, Martin C., Izeradjene, Kamel, Rani, P. Geetha, Feng, Libing, Carlson, Markus A., DelGiorno, Kathleen E., Wood, Laura D., Goggins, Michael, Hruban, Ralph H., Chang, Amy E., Calses, Philamer, Thorsen, Shelley M., Hingorani, Sunil R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458240/
https://ncbi.nlm.nih.gov/pubmed/26004068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2015.04.048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller